Taigen Biopharmaceuticals Holdings Ltd (4157.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Taiwan · ISIN KYG866171005
Taigen Biopharmaceuticals Holdings Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 150.65 m TWD | 259.47 m TWD |
| Gross profit | 134.52 m TWD | 241.30 m TWD |
| Operating income | -122.10 m TWD | 69.40 m TWD |
| EBIT | -31.46 m TWD | 59.11 m TWD |
| Net income | -38.58 m TWD | 45.18 m TWD |
| Diluted EPS – continuing operations | -0.05 TWD | 0.06 TWD |
Full history since 2010, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Taigen Biopharmaceuticals Holdings Ltd
TaiGen Biopharmaceuticals Holdings Limited, a pharmaceutical company, develops novel therapeutics for transformative diseases worldwide. The company develops Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic for the treatment of bacterial infections. Its product pipeline comprises Taigexyn, which is in phase II clinical trial for the treatment of community-acquired pneumonia/diabetic foot infection; TG-1000, which is in phase III clinical trial to treat influenza A and B; TG-4318; ISM-4808 to treat CKD anemia; Furaprevir, a HCV protease inhibitor for the treatment of chronic hepatitis C; and Burixafor, a stem cell mobilizer which is in phase II clinical trial for stem cell transplantation and chemosenzitization. In addition, the company is involved in the provision of consultation on pharmaceutical technology; and manufacture and sale of health food. The company was founded in 2001 and is based in Taipei City, Taiwan.
More stocks
- Pyxis Oncology, Inc. (PYXS)
- Syscom Computer Engineering Co (2453.TW)
- Universal Microelectronics Co Ltd (2413.TW)
- Vente Unique.com (ALVU.PA)
- Daemyoung Energy Co Ltd (389260.KQ)
- Jasuindo Tiga Perkasa Tbk (JTPE.JK)
- GTM Holdings Corp (1437.TW)
- BridgeBio Oncology Therapeutics, Inc. (BBOT)
- Inergy Technology Inc. (6693.TWO)
- AME REIT (5307.KL)
- Songwon Industrial (004430.KS)
- NanoXplore Inc (GRA.TO)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.